Interactions between D1 and D2 Dopamine Receptor Mechanisms: The Immediate Early Response Gene C-Fos in Long-Term Changes in the Striatum

  • H. A. Robertson
  • M. L. Paul
  • G. S. Robertson
Part of the Advances in Behavioral Biology book series (ABBI, volume 39)


As recently as 1984, it was possible to refer to the D2 dopamine site as the only functional, behaviourally relevant dopamine receptor; the significance of the D1 site, beyond adenylate cyclase stimulation, was unknown (Grigoriadis and Seeman, 1984). It is now clear that Dl and D2 dopamine receptor mechanisms interact in such a way as to produce additive or synergistic effects on many behavioural and movement-related functions in rats, mice, monkeys and, most likely, in man. The exact mechanisms by which this occurs remains obscure. Here we review the evidence for additive or synergistic effects of D1 and D2 receptor mechanisms and discuss the anatomical implications of these findings. Interaction between D1 and D2 dopamine receptor mechanism may also have important long-term consequences. These long-term consequences include important clinical phenomena such as the tardive dyskinesias and dystonias. In addition to these movement disorders, there is at least reason to suspect that these mechanisms (D1/D2 receptor mechanism interaction, immediate early gene activation) might be involved in major psychiatric illnesses such as the schizophrenias. In animal studies, the phenomenon of dopaminergic “priming” may be a model for the sorts of long-term changes that occur clinically in these psychiatric illnesses and motor disturbances.


Dopamine Receptor Dopamine Agonist Tardive Dyskinesia Kindling Stimulation Striatonigral Neuron 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Anden, N.-E. and M. Grabowska-Anden, 1988, Stimulation of Dl dopamine receptors reveals direct effects of the preferential dopamine autoreceptor agonist B-HT 920 on postsynaptic dopamine receptors, Acta Physiol. Scand., 134: 285.Google Scholar
  2. Beckstead, R.M., Wooten, G.F. and Trugman, J.M., 1988, Distribution of Dl and D2 dopamine receptors in the basal ganglia of the cat determined by quantitative autoradiography, J. Comp. Neurol. 268: 131.Google Scholar
  3. Berridge, M.J., 1986, Second messenger dualism in neuromodulation and memory. Nature 323: 294.PubMedCrossRefGoogle Scholar
  4. Clark, D. and White, F.J., 1987, Dl dopamine receptor-the search for a function, Synapse 1: 347.PubMedCrossRefGoogle Scholar
  5. Criswell, H., Mueller, R.A. and Breese, G.R., 1989, Priming of Dl-dopamine receptor responses: long-lasting behavioral supersensitivity to a Dl-dopamine agonist following repeated administration to neonatal 6-OHDAlesioned rats, J. Neurosci. 9: 125.PubMedGoogle Scholar
  6. Dragunow, M. and Robertson, H.A., 1987, Kindling stimulation induces c-fos protein(s) in granule cells of the rat dentate gyrus, Nature 329: 441.Google Scholar
  7. Dreher, J.K. and Jackson, D.M., 1989, Role of Dl and D2 dopamine receptors in mediating locomotor activity elicited from the nucleus accumbens of rats, Brain Res. 487: 267.PubMedCrossRefGoogle Scholar
  8. Filloux, F., Dawson, T.M. and Wamsley, J.K., 1988a, Localization of nigrostriatal dopamine receptor subtypes and adenylate cyclase, Brain Res. Bull. 20: 447.CrossRefGoogle Scholar
  9. Filloux, F., Liu, T.H., Hsu, C.Y., Hunt, M.A. and Wamsley, J.K., 1988b, Selective cortical infarction reduces 3H-sulpiride binding in rat caudateputamen: autoradiographic evidence for presynaptic D2 receptors on corticostriate terminals, Synapse 2: 521.PubMedCrossRefGoogle Scholar
  10. Grigoriadis, D. and Seeman, P., 1984, The dopamine/neuroleptic receptor, Can. J. Neurol. Sci. 4: 108.Google Scholar
  11. Jackson, D.M., Ross, S.B. and Hashizume, M., 1988, Further studies on the interaction between bromocriptine and SKF 38393 in reserpine and alpha methyl-para-tyrosine-treated mice, Psychopharmacol. 94: 321.Google Scholar
  12. Liebman, J.M., Gerber, R., Hall, N.R. and Altar, C.A., 1988, Heterologous rotational responsiveness in 6-hydroxydopamine-denervated rats: pharmacological and neurochemical characterization, Psychopharmacol. 96: 477.CrossRefGoogle Scholar
  13. Maura, G., Giardi, A. and Raiteri, M., 1988, Release-regulating D2 dopamine receptors are located on striatal glutamatergic nerve terminals, J. Pharmacol. Exp. Therap. 247: 680.Google Scholar
  14. Meador-Woodruff, J.H., Mansour, A., Bunzow, J.R., Van Tol, H.H.M., Watson Jr., S.J. and Civelli, 0., 1989, Distribution of D2 dopamine receptor mRNA in rat brain, Proc. Nat. Acad. Sci. U.S.A. 86: 7625 (1989).Google Scholar
  15. Mengod, G., Martinez-Mir, M.I., Vilaro, M.T. and Palacios, J.M., 1989, Localization of the mRNA for the dopamine D2 receptor in the rat brain by in situ hybridization histochemistry, Proc. Nat. Acad. Sci. U.S.A. 86: 8560.Google Scholar
  16. Morelli, M. and Di Chiara, G., 1987, Agonist-induced homologous and heterologous sensitization to D-1 and D-dependent contraversive turning, Eur. J. Pharmacol. 141: 101.Google Scholar
  17. Morelli, M., Fenu, S. and Di Chiara, G., 1987, Behavioural expression of D1-receptor supersensitivity depends on previous stimulation of D-2 receptors, Life Sci. 40: 245.PubMedCrossRefGoogle Scholar
  18. Morelli, M., Mennini, T. and Di Chiara, G., 1988, Nigral dopamine autoreceptors are exclusively of the D2 type: quantitative autoradiography of [125I]iodosulpride and [1251]SCH 23982 in adjacent brain sections, Neuroscience 27: 865.PubMedCrossRefGoogle Scholar
  19. B.Morris, B.J., Feasey, K.J., ten Bruggencate, G., Herz, A. and Höllt, V., 1988, Electrical stimulation in vivo increases the expression of proenkephalin mRNA and decreases the expression of prodynorphin mRNA in rat hippocampal granule cells, Proc. Natl. Acad. Sci. U.S.A. 85: 3226.Google Scholar
  20. Robertson, H.A. and Robertson, G.S., 1987a, Combined L-dopa and bromocriptine therapy for Parkinson’s disease: a proposed mechanism of action, Clinical Neuropharmacol. 10: 384.CrossRefGoogle Scholar
  21. Robertson, G.S. and Robertson, H.A., 1987b, Dl and D2 agonist synergism: separate sites of action? Trends Pharmacol. Sci. 8: 295.Google Scholar
  22. Robertson, G.S. and Robertson, H.A., 1988, Evidence that the substantia nigra is a site of action for L-dopa, Neurosci. Lett. 89: 204.Google Scholar
  23. Robertson, G.S. and Robertson, H.A., 1989, Evidence that L-Dopa-induced Rotational Behaviour is Dependent on Both Striatal and Nigral Mechanisms, J. Neurosci. 9: 3326.PubMedGoogle Scholar
  24. Robertson, G.S., Herrera, D.G., Dragunow, M. and Robertson, H.A., 1989a, L-DOPA activates c-fos in the striatum ipsilateral to a 6-hydroxydopamine lesion of the substantia nigra, Eur. J. Pharmacol. 159: 99.PubMedCrossRefGoogle Scholar
  25. Robertson, H.A., Peterson, M.R., Murphy K. and Robertson, G.S., 1989b, D1 dopamine receptor agonists selectively activate striatal c-fos independent of rotational behaviour, Brain Research 503: 346.PubMedCrossRefGoogle Scholar
  26. Rosengarten, H., Schweitzer, J.W. and Friedhoff, A.J., 1983, Induction of oral dyskinesias in naive rats by D1 stimulation, Life Sci. 33: 2479.PubMedCrossRefGoogle Scholar
  27. Rouillard, C. and Bedard, P.J., 1988, Specific Dl and D2 dopamine agonists have synergistic effects in the 6-hydroxydopamine circling model in the rat, Neuropharmacol. 27: 1257.CrossRefGoogle Scholar
  28. Rubinstein, M., Gershanik, 0. and Stefano, F.J.E., 1988, Different roles of D1 and D2 receptors involved in locomotor activity in supersensitive mice. Eur. J. Pharmacol. 148: 419.PubMedCrossRefGoogle Scholar
  29. Sagar, S.M., Sharp, F.R. and Curran, T., 1988, Expression of c-fos protein in brain: Metabolic mapping at the cellular level, Science 240: 1328.PubMedCrossRefGoogle Scholar
  30. Savasta, M., Dubois, A. and Scatton, B., 1986, Autoradiographic localization of D1 dopamine receptors in the rat brain with [3H]-SCH 23390, Brain Res. 375: 291.PubMedCrossRefGoogle Scholar
  31. Sonsalla, P.K., Manzino, L. and Heikkila, R.E., 1988, Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway, J. Pharmacol. Exp. Therap. 247: 180.Google Scholar
  32. Starke, K., Spath, L., Lang, J.D. and Adelung, C., 1983, Further functional in vitro comparison of pre-and postsynaptic dopamine receptors in the rabbit caudate nucleus, Naunyn-Schmiedeberg’s Arch. Pharmacol. 323: 298.Google Scholar
  33. Stoof, J.C. and Verheijden, P.F.H.M., 1986, D2 receptor stimulation inhibits cyclic AMP formation brought about by D1 receptor stimulation in the rat neostriatum but not nucleus accumbens, Eur. J. Pharmacol. 129: 205.Google Scholar
  34. Sutula, T., Xiao-Xian, H., Cavazos, J. and Scott, G., 1988, Synaptic reorganization in the hippocampus induced by abnormal functional activity, Science 239: 1147.PubMedCrossRefGoogle Scholar
  35. Trugman, J.M., Geary, II, W.A. and Wooten, G.F., 1986, Localization of D2 dopamine receptors to intrinsic striatal neurons by quantitative autoradiography, Nature 292: 463.Google Scholar
  36. Trugman, J.M. and G.F. Wooten, G.F., 1987, Selective D-1 and D-2 dopamine agonists differentially alter basal ganglia glucose utilization in rats with unilateral 6-Hydroxydopamine substantia nigra lesions. J. Neurosci. 7: 2927.Google Scholar
  37. Ungerstedt, U., 1971, Postsynaptic supersensitivity after 6-hydroxydopamine induced degeneration of the nigrostriatal dopamine system, Acta Physiol. Scand. (suppl.) 367: 69.Google Scholar
  38. Waddington, J.L. and O’Boyle, K.M., 1987 The D1 dopamine receptor and the search for its functional role: from neurochemistry to behaviour, Reviews in the Neurosciences 1: 157.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1991

Authors and Affiliations

  • H. A. Robertson
    • 1
  • M. L. Paul
    • 1
  • G. S. Robertson
    • 1
  1. 1.Department of PharmacologyDalhousie UniversityHalifax, Nova ScotiaCanada

Personalised recommendations